Why Are Employers Dropping GLP-1 Coverage?
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
Written by:
GLP-1s, touted as a miracle drug by many, are slowly disappearing from Americans' insurance plans. Bloomberg workplace reporter Taylor Nicole Rogers explains why companies are saying “no thanks” to one of the hottest classes of pharmaceuticals on the market. And then, what would you do if you were in $30,000 of credit card debt? Debt Heads podcast co-host Jamie Feldman gives her negative balance a casual shrug, and makes the argument that you should too.
See omnystudio.com/listener for privacy information.
adbl_web_anon_alc_button_suppression_t1
No reviews yet